Heartseed
Last updated: April 19, 2024
CEO Keiichi Fukuda
Country: Japan | Funding: $86.3M (+)
Website: http://heartseed.jp/en/
Heartseed is a biotech company developing iPSC-derived highly purified ventricular cardiomyocytes for heart failure
Website: http://heartseed.jp/en/
Heartseed is a biotech company developing iPSC-derived highly purified ventricular cardiomyocytes for heart failure